SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-18-015606
Filing Date
2018-11-14
Accepted
2018-11-14 06:44:05
Documents
1
Group Members
MVA 151 INVESTORS, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d1118schuyl_adialpharma.htm SC 13D 150580
  Complete submission text file 0001213900-18-015606.txt   152107
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Subject) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90718 | Film No.: 181180311
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1180 SEMINOLE TRAIL, SUITE 495 CHARLOTTESVILLE VA 22901
Business Address
Schuyler Kevin (Filed by) CIK: 0001718094 (see all company filings)

Type: SC 13D